140 related articles for article (PubMed ID: 6161691)
1. Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer.
Bosl GJ; Lange PH; Fraley EE; Goldman A; Nochomovitz LE; Rosai J; Waldmann TA; Johnson K; Kennedy BJ
Cancer; 1981 Jan; 47(2):328-32. PubMed ID: 6161691
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of tumor cytosol and peripheral serum levels of human chorionic gonadotropin and alphafetoprotein in testicular cancer.
Javadpour N; Woltering E; Soares T
Invest Urol; 1980 Jul; 18(1):11-2. PubMed ID: 6157650
[TBL] [Abstract][Full Text] [Related]
3. [Staging of testicular cancer by ultrasound and tumor markers with special respect to stage I and IIA].
Behrendt H; Heckemann R; Meyer-Schwickerath M; Hartung R
Urol Int; 1983; 38(5):279-84. PubMed ID: 6195792
[TBL] [Abstract][Full Text] [Related]
4. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
5. Applications of biologic tumor markers in testicular cancer.
Javadpour N
Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers for testicular germ-cell tumors in relation to histology and stage: some experiences from the Danish testicular cancer (DATECA) Study from 1976 through 1981.
Nørgaard-Pedersen B; Schultz H; Arends J; Brincker H; Jacobsen GK; Lindeløv B; Rørth M; Svennekjaer IL
Ann N Y Acad Sci; 1983; 417():390-9. PubMed ID: 6200044
[TBL] [Abstract][Full Text] [Related]
7. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
Lippert MC; Javadpour N
Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
[TBL] [Abstract][Full Text] [Related]
8. Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
Fowler JE; Sesterhenn I; Stutzman RE; Mostofi FK
Urology; 1983 Dec; 22(6):649-54. PubMed ID: 6196899
[TBL] [Abstract][Full Text] [Related]
9. Significance of elevated serum alphafetoprotein (AFP) in seminoma.
Javadpour N
Cancer; 1980 Apr; 45(8):2166-8. PubMed ID: 6154525
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
11. False-positive and false-negative alpha-feto protein and human chorionic gonadotropin assays in testicular cancer: a double blind study.
Javadpour N; Soares T
Cancer; 1981 Nov; 48(10):2279-81. PubMed ID: 6170418
[TBL] [Abstract][Full Text] [Related]
12. Current status of tumor markers in testicular cancer. A practical review.
Javadpour N
Eur Urol; 1992; 21 Suppl 1():34-6. PubMed ID: 1385131
[TBL] [Abstract][Full Text] [Related]
13. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Javadpour N; McIntire KR; Waldmann TA
Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Javadpour N; McIntire KR; Waldmann TA
Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
[TBL] [Abstract][Full Text] [Related]
15. Ferritin - another tumor marker for testicular malignancies.
Engelmann U; Büber V; Riedmiller H; Jacobi GH
Eur Urol; 1981; 7(6):355-8. PubMed ID: 6169531
[TBL] [Abstract][Full Text] [Related]
16. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of stage I, II testicular tumor based on tumor markers].
Kamidono S; Arakawa S; Hamami G; Umezu K; Fujii A; Ishigami J
Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1383-93. PubMed ID: 6202917
[No Abstract] [Full Text] [Related]
18. Staging of early nonseminomatous germ-cell testicular cancer.
Fraley EE; Lange PH; Williams RD; Ortlip SA
Cancer; 1980 Apr; 45(7 Suppl):1762-7. PubMed ID: 6154518
[No Abstract] [Full Text] [Related]
19. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
[TBL] [Abstract][Full Text] [Related]
20. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
Dunzendorfer U; Jurincic C
Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
